R&D and LICENSING

THERAPEUTIC AREA PHARMACEUTICAL FORM EXPECTED LAUNCH
Ophthalmology/ Glaucoma eye-drops 2021 (IV)
Ophthalmology/ Glaucoma eye-drops 2024
Ophthalmology/NSAIDs eye-drops in gel 2025
Vascular disease (Hemorrhoids) proctologic cream 2020 (IV)
Vascular disease (Antithrombotic) solution for injection 2021 (II)
PATENT APPLICATION PCT/IB2011/050663        
TITLE DOCUMENT TOPICAL CITICOLINE
FOR THE TREATMENT
OF GLAUCOMA
       
    APPLICATION NUMBER PUBLICATION STATUS TITLE DOCUMENT HOLDER
(PATENT HOLDER)
  PCT WO2011101802 25/08/2011   OMIKRON ITALIA
  NATIONAL STAGE EUROPE
PDF icon EP2538918
02/01/2013 GRANT OF PATENT IS
INTENDED
06/06/2014
OMIKRON ITALIA
  NATIONAL STAGE USA
PDF icon US8822429
13/12/2012 GRANT OF PATENT IS
INTENDED
13/08/2014
OMIKRON ITALIA
  NATIONAL STAGE JAPAN
PDF icon JP5801324
04/09/2015 GRANT OF PATENT IS
INTENDED
18/08/2015
OMIKRON ITALIA

 

PATENT APPLICATION PCT/IB2017/056400        
TITLE DOCUMENT OPHTHALMIC
FORMULATION
COMPRISING CITICOLINE
CARRIED BY LIPOSOME
FOR THE TREATMENT OF
GLAUCOMA
       
    APPLICATION NUMBER PUBLICATION STATUS TITLE DOCUMENT HOLDER
(PATENT HOLDER)
  PCT WO2018073720 26/04/2018    
  NATIONAL STAGE USA
PDF icon US 10576039
16/04/2019 GRANT OF PATENT IS INTENDED
03/03/2020
OMIKRON ITALIA
ABIOGEN PHARMA
Pisa - Italy
Glibenclamide + Meformin Hydrocloride (Diaglimet ®)
RRR-α-tochoperol (Armilla ®)
URSAPHARM Arzneimittel GmbH 
Germany
Retinol Palmitate (VitA-POS)
PREMIO SOI a Omikron Italia
Go to top